The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Letter to the EditorFull Access

Genetic Linkage in Schizophrenia

To the Editor: After not finding a susceptibility gene for schizophrenia, Dr. DeLisi et al. suggested that schizophrenia could result from variation in gene expression. They also recommended that investigators who choose candidate genes for schizophrenia take under consideration various defects observed in schizophrenia. I wish to add three additional recommendations.

First, successful identification of candidate genes for schizophrenia may be enhanced if the higher urban prevalence of schizophrenia is considered. Second, a variation of genetic expression could result from a pathological mechanism known as translational pathophysiology (1). Abnormalities of protein translation could allow genetic, infectious, and nutritional pathways to affect brain development. Third, investigators might consider that a schizophrenia gene enhances survival during prenatal growth.

Translational pathophysiology could result in both enhanced survival and schizophrenia if a gene that provides resistance to an infectious agent through translational interference is expressed during fetal growth and inhibits both viral and host proteins. I hypothesized this Darwinian approach in merging the literature on the flavivirus resistance gene with the geographies of schizophrenia and flaviviruses (2). In this context, the genetic resistance of certain mice to typhoid fever may also have application to schizophrenia. A critical genetic control of typhoid resistance is the natural resistance-associated macrophage protein 1 (NRAMP 1) (3). This gene enhances expression of several proteins, is expressed in neurons, and is associated with behavioral and immune responses to stress (4, 5). The human homologue maps to chromosome 2q35 (3), a location also linked to susceptibility to rheumatoid arthritis (4). Given the controversial hypothesis that persons with schizophrenia are resistant to rheumatoid arthritis, it is noteworthy that chromosome 2 was one of the few chromosomes in which Dr. DeLisi et al. found positive linkages.

References

1. Philips AV, Cooper TA: RNA processing and human disease. Cell Mol Life Sci 2000; 57:235-249Crossref, MedlineGoogle Scholar

2. Brown JS Jr: A novel mechanism to explain protein abnormalities in schizophrenia based on the flavivirus resistance gene. Mol Psychiatry 2001; 6:701-711Crossref, MedlineGoogle Scholar

3. Dunstan SJ, Ho VA, Duc CM, Lanh MN, Phuong CX, Luxemburger C, Wain J, Dudbridge F, Peacock CS, House D, Parry C, Hien TT, Dougan G, Farrar J, Blackwell JM: Typhoid fever and genetic polymorphisms at the natural resistance-associated macrophage protein 1. J Infect Dis 2001; 183:1156-1160Crossref, MedlineGoogle Scholar

4. Shaw MA, Clayton D, Atkinson SE, Williams H, Miller N, Sibthorpe D, Blackwell JM: Linkage of rheumatoid arthritis to the candidate gene NRAMP1 on 2q35. J Med Genet 1996; 33:672-677Crossref, MedlineGoogle Scholar

5. Evans CA, Harbuz MS, Ostenfeld T, Norrish A, Blackwell JM: Nramp1 is expressed in neurons and is associated with behavioural and immune responses to stress. Neurogenetics 2001; 3:69-78Crossref, MedlineGoogle Scholar